Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerhartz

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Onkologie|February 1, 1989
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German resultsW Linkesch, G Michlmayr, H Gerhartz, et al.
Hematological Oncology|January 1, 1988
CHOP and COPBLAM chemotherapy for diffuse large cell non-Hodgkin's lymphomas: a retrospective comparisonH H Gerhartz, E Thiel, E Hiller, et al.
Onkologie|April 1, 1987
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3]V Diehl, M Pfreundschuh, M Löffler, et al.
Deutsche Medizinische Wochenschrift (1946)|July 26, 1991
[HIV-associated lymphomas]C Scheidegger, B Heinrich, M Popescu, et al.
International Journal of Cell Cloning|March 1, 1984
Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimerasF Carbonell, W Calvo, T M Fliedner, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 17, 1986
[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group]V Diehl, M Pfreundschuh, F E Hauser, et al.
International Journal of Cancer|November 15, 1988
Epstein-Barr virus-positive recipient type B-cells survive in a "complete chimera" after allogeneic bone-marrow transplantationH H Gerhartz, J Mittermüller, A Raghavachar, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapyM Engelhard, P Meusers, G Brittinger, et al.
Onkologie|February 1, 1988
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group]M Pfreundschuh, M Löffler, U Rühl, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Onkologie|February 1, 1989
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German resultsW Linkesch, G Michlmayr, H Gerhartz, et al.
Hematological Oncology|January 1, 1988
CHOP and COPBLAM chemotherapy for diffuse large cell non-Hodgkin's lymphomas: a retrospective comparisonH H Gerhartz, E Thiel, E Hiller, et al.
Onkologie|April 1, 1987
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3]V Diehl, M Pfreundschuh, M Löffler, et al.
Deutsche Medizinische Wochenschrift (1946)|July 26, 1991
[HIV-associated lymphomas]C Scheidegger, B Heinrich, M Popescu, et al.
International Journal of Cell Cloning|March 1, 1984
Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimerasF Carbonell, W Calvo, T M Fliedner, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 17, 1986
[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group]V Diehl, M Pfreundschuh, F E Hauser, et al.
International Journal of Cancer|November 15, 1988
Epstein-Barr virus-positive recipient type B-cells survive in a "complete chimera" after allogeneic bone-marrow transplantationH H Gerhartz, J Mittermüller, A Raghavachar, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapyM Engelhard, P Meusers, G Brittinger, et al.
Onkologie|February 1, 1988
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group]M Pfreundschuh, M Löffler, U Rühl, et al.
Pageof 12